Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The Evolution of the Axillofemoral Bypass over Two Decades

The Evolution of the Axillofemoral Bypass over Two Decades To determine if the indications and numbers of the axillofemoral bypass have changed, a retrospective analysis was performed of all patients undergoing axillofemoral bypass over the past two decades. Group A (1980-89) and group B (1990-99) were compared using demographics, comorbid illness, perioperative outcomes, and indications for operation. There were 33 extraanatomic bypasses performed in group A and 24 extraanatomic bypasses in group B. The average age in both group A and group B was 69 years. Males comprised a higher percentage in group B (75%) than in group A (55%). The percentage of smokers was roughly equivalent (group A 76%, group B 71%). Coronary artery disease was more prevalent in group A (85%) than in group B (63%). Diabetes mellitus was also more common in group A (33%) than in group B (21%). All of the grafts in group B were composed of PTFE and there were 2 early (30 day) failures (6%). There were no perioperative deaths, strokes, or myocardial infarctions. At our institution, the axillofemoral bypass is now reserved almost exclusively for the treatment of graft infections and rarely for primary limb ischemia. This evolution is a reflection of the increase in interventional techniques used to improve inflow in high-risk patients who require revascularization. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of Vascular Surgery Springer Journals

The Evolution of the Axillofemoral Bypass over Two Decades

Download PDF
4 pages

Loading next page...
 
/lp/springer-journals/the-evolution-of-the-axillofemoral-bypass-over-two-decades-VblNiGHoy7

References (14)

Publisher
Springer Journals
Copyright
Copyright © Inc. by 2002 Annals of Vascular Surgery
Subject
Medicine & Public Health; Abdominal Surgery
ISSN
0890-5096
eISSN
1615-5947
DOI
10.1007/s10016-001-0182-9
pmid
12424558
Publisher site
See Article on Publisher Site

Abstract

To determine if the indications and numbers of the axillofemoral bypass have changed, a retrospective analysis was performed of all patients undergoing axillofemoral bypass over the past two decades. Group A (1980-89) and group B (1990-99) were compared using demographics, comorbid illness, perioperative outcomes, and indications for operation. There were 33 extraanatomic bypasses performed in group A and 24 extraanatomic bypasses in group B. The average age in both group A and group B was 69 years. Males comprised a higher percentage in group B (75%) than in group A (55%). The percentage of smokers was roughly equivalent (group A 76%, group B 71%). Coronary artery disease was more prevalent in group A (85%) than in group B (63%). Diabetes mellitus was also more common in group A (33%) than in group B (21%). All of the grafts in group B were composed of PTFE and there were 2 early (30 day) failures (6%). There were no perioperative deaths, strokes, or myocardial infarctions. At our institution, the axillofemoral bypass is now reserved almost exclusively for the treatment of graft infections and rarely for primary limb ischemia. This evolution is a reflection of the increase in interventional techniques used to improve inflow in high-risk patients who require revascularization.

Journal

Annals of Vascular Surgery – Springer Journals

Published: Dec 11, 2002

There are no references for this article.